Skip to main content

beta This is a new site, your feedback will help us to improve it.

Cell Therapy Development

Published on 14 October 2021

Research into cell therapy to repair damaged tissue or to direct the immune system to reject infections or tumours has the potential to revolutionise the treatment of numerous diseases.

The Scottish National Blood Transfusion Service Cellular Therapeutics is based at the Scottish Centre for Regenerative Medicine (SCRM) in Edinburgh and at the Jack Copland Centre. Scientists from SNBTS work in partnership with colleagues from quality assurance, regulatory compliance and laboratory testing, as well as colleagues from the University of Edinburgh and the Cell and Gene Therapy Catapultinter alia to create a centre of excellence for cellular therapy.

Current cellular therapy development within SNBTS includes:

  • EBV-specific T cells to treat Post Transplant Lymphoproliferative Diseases
  • Autologous Macrophages for the treatment of Cirrhosis - the MATCH Trial.